Funding Status: N/A
Headquarters: New York, New York, United States
Founded Date: 6-26
Employee Number: 11-50
Last Funding Type: Grant
Total Funding: $51.6M
Estimated Revenue: Less than $1M
Industry: Neuropharmacology
Investors Number: 5
Technology: Regenerative Medicine
Investor Type: Company
Number Of Exists: Grant
Investment Stage: N/A